U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07479628) titled 'Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma' on March 05.
Brief Summary: The goal of this clinical trial (Phase II) is to evaluate the efficacy and safety of neoadjuvant Adebrelimab combined with chemoradiation in patients with locally advanced thymic carcinoma. The main questions it aims to answer are:
* Is neoadjuvant therapy with Adebrelimab plus chemoradiation effective?
* Is this combination treatment safe and tolerable in this patient population?
Participants will:
* Receive 2-4 cycles of neoadjuvant Adebrelimab combined with a platinum-based chemotherapy regimen (such as carboplatin plus paclit...